Home Your basket
• Fibrous dysplasia, a case...
   Price 10.50 €
• Vocal and behavioral adap...
   Price 10.50 €
• Benign paroxysmal vertigo...
   Price 8.50 €
• Hypersensitivity to inhal...
   Price 10.50 €
• Nasal glioma, diagnosis i...
   Price 12.00 €
• TRT: Results after one ye...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• Endoscopic sphenoid proce...
   Price 8.50 €
• Forcing the voice : the c...
   Price 5.50 €
• Chronic laryngitis...
   Price 8.50 €
• Vibrant Soundbridge middl...
   Price 10.50 €
• Smile "forced" smile vers...
   Price 10.50 €
• Predictive factors for su...
   Price 15.00 €
• Non-functioning parathyro...
   Price 5.50 €
• The verrucous laryngeal c...
   Price 5.50 €
• Congenital cyst and fistu...
   Price 10.50 €
• Bilateral and recurrent f...
   Price 5.50 €
• Surgical procedure in fir...
   Price 8.50 €
• Quality of life before an...
   Price 10.50 €
• Anatomy of the external a...
   Price 14.00 €
• Dynamic palatography: Dia...
   Price 12.50 €
• Botulinum toxin, descript...
   Price 12.50 €
• Assessment of migraine re...
   Price 8.50 €
• Results of six years expe...
   Price 8.50 €
• Brain stem cavernous angi...
   Price 8.50 €
• Teratoma of the parotid g...
   Price 5.50 €
• Laryngeal dystonia and as...
   Price 8.50 €
• Pyogenic granuloma of the...
   Price 8.50 €
• Choanal atresia: therapeu...
   Price 10.50 €
• Formant structures of vow...
   Price 10.50 €
• Why is allergic rhinitis ...
   Price 12.00 €

Total Order 292.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2010 o

PHONIATRICS

Voice related quality of life after botulinum toxin injection for spasmodic dysphonia


Authors : Gama A. C. C. 1<br />Menezes LN, Maia AA, Rezende Neto AL, Oliveira JB. (Belo Horizonte)

Ref. : Rev Laryngol Otol Rhinol. 2010;131,1:39-44.

Article published in english
Downloadable PDF document english



Summary : Introduction: Laryngeal Focal Dystonia (LFD) leads to a type of voice with a strained and tense quality which has a neurological origin, affecting the social-emotional realms of the individuals, and their quality of life. Aims: Measure the voice-related quality of life of patients with Adductor LFD pre and post-treatment with Botox®‚ injection followed by voice therapy, using the Voice-Related Quality of Life (V-RQOL). Study Design: Prospective study. Methods: Adductor 11 female patients aged between 33 and 74 years with a diagnosis of Adductor LFD were evaluated. All patients underwent a neurological evaluation. Laryngoscopy was performed with both rigid and flexible endoscopes. Speech and Language evaluation followed the Evaluation of Voice Protocol, proposed by Behlau, Pontes (1995). The American V-RQOL measure was utilized. Results: Statistical analysis demonstrated significant difference (p< 0,05). 81.8% of patients showed higher scores post-Botox®‚ for the social-emotional and physical domain. In the overall V-RQOL scores 72.7% of patients showed greater scores post-treatment. Conclusions: There was an improvement in the quality of life for these patients post-treatment. The V-RQOL proved to be an efficient tool to measure the treatment outcomes of LFD pre and post botulinum toxin injection.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE